A Study to Evaluate Skin and Plasma Pharmacokinetic of Multiple Doses of Povorcitinib After Oral Administration in Healthy Participants
Clinical trial NCT06505265 · COMPLETED
Trial details
- NCT number
- NCT06505265
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-12
- Primary completion
- 2024-09-18
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.